We are live on ! Find out more
CGTX icon

Cognition Therapeutics
CGTX

36 hedge funds and large institutions have $10.4M invested in Cognition Therapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

3% more funds holding

Funds holding: 35 → 36 (+1)

0.38% less ownership

Funds ownership: 24.25% → 23.87% (-0.38%)

20% less capital invested

Capital invested by funds: $13M → $10.4M (-$2.57M)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
36
Holders Change
+1
Holders Change %
+2.86%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
7
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CC
Carlson Capital
Texas
+$70.5K
2
SFG
Steward Financial Group
Texas
+$64K
3
State Street
State Street
Massachusetts
+$32.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$28.9K
5
HighTower Advisors
HighTower Advisors
Illinois
+$10K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.42K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$2.66K
3
UBS Group
UBS Group
Switzerland
-$1.12K
4
TRCT
Tower Research Capital (TRC)
New York
-$1.1K
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$791
Name Holding Trade Value Shares
Change 		Change in
Stake
PFO
1
Pathstone Family Office
New Jersey
$3.18M – – –
ACM
2
AIGH Capital Management
Maryland
$2.94M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$989K +$28.9K +18,471 +3%
WVP
4
Worth Venture Partners
New Jersey
$733K – – –
CC
5
Carlson Capital
Texas
$418K +$70.5K +45,000 +18%
PWM
6
Perigon Wealth Management
California
$322K – – –
AFG
7
American Financial Group
Ohio
$295K – – –
KAS
8
Kestra Advisory Services
Texas
$257K +$7.83K +5,000 +3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$252K -$2.66K -1,700 -1%
Commonwealth Equity Services
10
Commonwealth Equity Services
Massachusetts
$134K -$791 -505 -0.5%
BCM
11
Bridgeway Capital Management
Texas
$95.3K – – –
VC
12
Voss Capital
Texas
$86.7K – – –
BlackRock
13
BlackRock
New York
$81K -$3.42K -2,184 -4%
FC
14
FCA Corp
Texas
$74.1K – – –
State Street
15
State Street
Massachusetts
$73.1K +$32.1K +20,500 +68%
CWM
16
Castle Wealth Management
Florida
$62.5K – – –
SFG
17
Steward Financial Group
Texas
$58K +$64K +40,874 New
NCM
18
Neumann Capital Management
California
$48.1K – – –
HighTower Advisors
19
HighTower Advisors
Illinois
$47K +$10K +6,401 +24%
Northern Trust
20
Northern Trust
Illinois
$44.2K – – –
NFC
21
Northeast Financial Consultants
Connecticut
$35.3K – – –
BSB
22
Bangor Savings Bank
Maine
$34.6K – – –
Baird Financial Group
23
Baird Financial Group
Wisconsin
$32.2K – – –
Morgan Stanley
24
Morgan Stanley
New York
$31.5K – – –
Bank of New York Mellon
25
Bank of New York Mellon
New York
$25.6K – – –
1
2

CGTX Hedge Fund Activity: Q3 2023 in Review

36 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2023, worth a combined $10.4M — down 20% from $13M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CGTX positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Carlson Capital, adding an estimated $70.5K. The largest seller was BlackRock, cutting an estimated $3.42K.

  • 36 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2023, up from 35 in Q2 2023.
  • Funds reported $10.4M of Cognition Therapeutics stock for Q3 2023, down 20% quarter-over-quarter.
  • 2 funds opened new Cognition Therapeutics positions in Q3 2023 and 1 closed out, a net change of +1 holder.
  • The largest Cognition Therapeutics buyer in Q3 2023 was Carlson Capital, an estimated $70.5K added.
  • The largest Cognition Therapeutics seller in Q3 2023 was BlackRock, an estimated $3.42K sold.

Based on aggregated 13F filings for Q3 2023.